Goldman Sachs Group (GS) 211.05 $GS SmarTrend Watching

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Goldman Sachs Group (GS) 211.05 $GS

SmarTrend Watching for Potential Rebound in Shares of Goldman Sachs Group After 1.03% Loss
Comtex SmarTrend(R) - 2 hrs 9 mins ago
Goldman Sachs Group (NYSE:GS) traded in a range yesterday that spanned from a low of $210.70 to a high of $214.61. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $210.75 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GS: 211.05 (-2.20)

After Yesterday's Decline of 1.03%, Goldman Sachs Group Offers Investors Better Value
Comtex SmarTrend(R) - 2 hrs 10 mins ago
Goldman Sachs Group (NYSE:GS) traded in a range yesterday that spanned from a low of $210.70 to a high of $214.61. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $210.75 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GS: 211.05 (-2.20)

Citigroup to Pay $140M Fine, Shut Down Banamex USA Unit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 23, 2:13PM CDT
Putting an end to the regulatory probe over its three-branch Banamex (Banco Nacional de Mexico) USA subsidiary, Citigroup Inc. (C) has decided to shut down the unit. Notably, the closure follows on the agreement by Citigroup to pay $140 million as settlement to regulators over loopholes in its anti-money laundering (AML) program.
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), DB: 33.83 (+0.40)

How to Trade 5 Big Stocks for Big Gains -- Must-See Charts
at The Street - Thu Jul 23, 11:42AM CDT
Here's a technical look at how to trade some of the biggest stocks on Wall Street.
HD: 114.59 (-0.31), V: 71.75 (-0.22), GS: 211.05 (-2.20), CNI: 60.22 (-0.78), PFE: 34.78 (-0.10)

'Showdown Year' for Cyber-Attacks Has Hackers Demanding Ransom in Bitcoin
at The Street - Thu Jul 23, 6:41AM CDT
Regulators are urging companies to ramp up cyber-security systems to protect both their own businesses and their customers' data as Finra recounts extortion attempts by hackers seeking ransom in Bitcoin.
HD: 114.59 (-0.31), GS: 211.05 (-2.20), JPM: 69.64 (-0.44), EBAY: 28.43 (-0.02), MS: 39.94 (-0.60)

Citigroup "Fully Reserved" for $770M CFPB Settlement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 3:40PM CDT
If you are a Citigroup Inc. (C) credit card holder, your bank might owe you some money. The global banking giant will soon refund roughly $700 million to nearly 8.8 million customers who were victimized by illegal credit card practices at its Global Consumer Banking ("GCB" unit.
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), DB: 33.83 (+0.40)

Home Depot to Buy Construction Pro Supplier Interline Brands
at The Street - Wed Jul 22, 2:57PM CDT
Home Depot said Wednesday it would acquire privately held Interline Brands, a distributor and vendor of maintenance and repair supplies, for $1.625 billion, strengthening its offerings for professional contractors.
HD: 114.59 (-0.31), GS: 211.05 (-2.20)

Jim Cramer's 'Mad Money' Recap: Seeing a Double Standard in Market Valuations
at The Street - Tue Jul 21, 7:23PM CDT
Cramer says Apple is in a tug of war between the bull and bears, and the bears seem to be winning.
RH: 104.78 (-0.85), BLK: 346.44 (-3.56), UTX: 101.14 (-0.41), C: 59.87 (-0.47), RTH: 77.78 (-0.77), YRCW: 12.79 (-0.27), UPS: 96.11 (-1.12), YHOO: 39.21 (-0.03), INSY: 44.25 (+0.42), JPM: 69.64 (-0.44), IBM: 161.73 (+1.38), CMG: 725.94 (+0.12), AAPL: 125.16 (-0.06), MBLY: 60.66 (unch), AMBA: 122.99 (+0.49), GPRO: 63.95 (+2.27), WLL: 24.51 (+0.20), BAC: 18.18 (-0.27), WFC: 58.21 (-0.31), TIF: 95.24 (+0.48), MS: 39.94 (-0.60), NFLX: 110.10 (-1.40), AA: 9.96 (-0.03), GS: 211.05 (-2.20), JWN: 78.02 (-0.97), CVX: 92.94 (-0.57)

JPMorgan, Goldman Sachs Prepped for the Pain of Volcker Rule
at The Street - Tue Jul 21, 2:24PM CDT
The Volcker Rule limiting proprietary trading at U.S. banks took effect on Tuesday. Rather than bar specific transactions, it tries to limit fallout on taxpayers, said former Congressman Barney Frank.
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), BAC: 18.18 (-0.27), MS: 39.94 (-0.60)

Banks for the Tech-Savvy Eliminate Everything But the Mobile App
at The Street - Tue Jul 21, 11:30AM CDT
App-only banks still have to convince prospective customers that their money is just as safe -- and just as real -- as it would be in a vault.
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), WFC: 58.21 (-0.31), BAC: 18.18 (-0.27)

Fed's 'Tough' Stance on Big Banks Isn't That Tough
at The Street - Tue Jul 21, 10:16AM CDT
The Federal Reserve is going to require the eight largest commercial banks to meet more restrictive capital requirements. Most already have, and they have until 2019 to do so anyway.
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), MS: 39.94 (-0.60)

Bullish Banking Earnings Drive Up These ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 21, 6:30AM CDT
A great start to the earnings season put these financial ETFs in focus.
GS: 211.05 (-2.20), VFH: 51.37 (-0.45), JPM: 69.64 (-0.44), KBWB: 41.01 (-0.41), C: 59.87 (-0.47), BAC: 18.18 (-0.27), WFC: 58.21 (-0.31), IYG: 97.29 (-1.00), XLF: 25.36 (-0.22), MS: 39.94 (-0.60)

Morgan Stanley Q2 trading up
at Investor's Business Daily - Mon Jul 20, 5:40PM CDT
The N.Y.-based lender's Q2 EPS excluding items was 79 cents, beating views by 5 cents. Excluding accounting adjustments, revenue rose 12.2% to $9.6 bil, beating estimates of $9.1 bil. Trading revenue rose 32.4% to $3.5 bil. Fixed income and...
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), BAC: 18.18 (-0.27)

Morgan Stanley Outshines Banking Rivals with $300 Million Trading Growth
at The Street - Mon Jul 20, 5:31PM CDT
Morgan Stanley trumped its trading-business rivals in the past three months, posting a $300 million gain even as revenue from comparable activity declined at Goldman Sachs and JPMorgan.
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), MS: 39.94 (-0.60)

JPMorgan Hit Hardest Under Fed's $200 Billion Crisis-Prevention Plan
at The Street - Mon Jul 20, 5:30PM CDT
JPMorgan Chase will have to set aside the most capital reserves, about $66 billion, under a new Federal Reserve rule designed to help safeguard against another financial crisis.
STT: 79.71 (-1.11), GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), WFC: 58.21 (-0.31), BAC: 18.18 (-0.27), BK: 44.47 (-0.26), MS: 39.94 (-0.60)

Fed OKs $200 Bil Capital Cushion At Top 8 Banks
at Investor's Business Daily - Mon Jul 20, 2:35PM CDT
The Federal Reserve Board on Monday approved a final rule directing JPMorgan Chase (JPM) and seven other large U.S. banks to hold more equity capital at higher than current industry requirements. The move is designed to create a cushion against...
STT: 79.71 (-1.11), GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), WFC: 58.21 (-0.31), BAC: 18.18 (-0.27), BK: 44.47 (-0.26), MS: 39.94 (-0.60)

Morgan Stanley Only Top Bank To See Q2 Trading Gain
at Investor's Business Daily - Mon Jul 20, 12:41PM CDT
Morgan Stanley (MS) was the only big bank to report an increase in trading revenue during the second quarter, helping the investment banking giant top forecasts. The New York-based lender earned 85 cents a share for a net income of $1.8 billion, down...
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), BAC: 18.18 (-0.27), MS: 39.94 (-0.60)


Morgan Stanley 2Q profit tops estimates, helped by trading
By KEN SWEET - AP - Mon Jul 20, 12:39PM CDT
NEW YORK (AP) — Morgan Stanley's second-quarter results topped Wall Street's expectations Monday, as the investment bank's trading and wealth management businesses helped lift revenue.
1 Comment
GS: 211.05 (-2.20), JPM: 69.64 (-0.44), C: 59.87 (-0.47), MS: 39.94 (-0.60)

No Vow of Poverty for Goldman CEO Lloyd "God's Work" Blankfein
Alex DUMORTIER, CFA, The Motley Fool - Motley Fool - Mon Jul 20, 11:51AM CDT
This is a light week for economic data (with the exception of June new home sales data on Friday morning) , so traders will be focusing on corporate earnings. We'r e  entering the thick of the reporting season, with one-fifth of the...
GS: 211.05 (-2.20)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading